Your browser doesn't support javascript.
loading
Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy.
Herling, Carmen Diana; Klaumünzer, Marion; Rocha, Cristiano Krings; Altmüller, Janine; Thiele, Holger; Bahlo, Jasmin; Kluth, Sandra; Crispatzu, Giuliano; Herling, Marco; Schiller, Joanna; Engelke, Anja; Tausch, Eugen; Döhner, Hartmut; Fischer, Kirsten; Goede, Valentin; Nürnberg, Peter; Reinhardt, Hans Christian; Stilgenbauer, Stephan; Hallek, Michael; Kreuzer, Karl-Anton.
Afiliación
  • Herling CD; Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn.
  • Klaumünzer M; Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn.
  • Rocha CK; Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn.
  • Altmüller J; Cologne Center for Genomics, and.
  • Thiele H; Cologne Center for Genomics, and.
  • Bahlo J; Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn.
  • Kluth S; Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn.
  • Crispatzu G; Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn, Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases, University of Cologne, Cologne, Germany;
  • Herling M; Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn, Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases, University of Cologne, Cologne, Germany;
  • Schiller J; Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn.
  • Engelke A; Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn.
  • Tausch E; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany; and.
  • Döhner H; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany; and.
  • Fischer K; Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn.
  • Goede V; Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn.
  • Nürnberg P; Cologne Center for Genomics, and Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases, University of Cologne, Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
  • Reinhardt HC; Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn, Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases, University of Cologne, Cologne, Germany;
  • Stilgenbauer S; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany; and.
  • Hallek M; Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn, Cologne Excellence Cluster on Cellular Stress Response in Aging-Associated Diseases, University of Cologne, Cologne, Germany;
  • Kreuzer KA; Department of Internal Medicine I, Center of Integrated Oncology Cologne-Bonn.
Blood ; 128(3): 395-404, 2016 07 21.
Article en En | MEDLINE | ID: mdl-27226433

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Clorambucilo / Proteínas Proto-Oncogénicas p21(ras) / Proteínas de Unión a Telómeros / Cariotipo Anormal / Rituximab Tipo de estudio: Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Clorambucilo / Proteínas Proto-Oncogénicas p21(ras) / Proteínas de Unión a Telómeros / Cariotipo Anormal / Rituximab Tipo de estudio: Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2016 Tipo del documento: Article